The green tea polyphenol epigallocatechin-3-gallate (EGCG) restores CDKL5-dependent synaptic defects in vitro and in vivo
- Authors
- Type
- Published Article
- Journal
- Neurobiology of Disease
- Publisher
- Elsevier
- Publication Date
- May 01, 2020
- Volume
- 138
- Identifiers
- DOI: 10.1016/j.nbd.2020.104791
- PMID: 32032735
- PMCID: PMC7152796
- Source
- PubMed Central
- Keywords
- License
- Unknown
Abstract
• Epigallocatechin-3-gallate (EGCG) restores CDKL5-dependent synaptic defects in vitro; • Epigallocatechin-3-gallate (EGCG) restores CDKL5-dependent synaptic defects in vitro; • DYRK1A levels and activity is increased in CDKL5 deficient neurons;